Transitioning FIB-4 score: From fibrosis screening tool to key biomarker for clinical endpoints

J Hepatol. 2024 Nov;81(5):e228-e229. doi: 10.1016/j.jhep.2024.05.018. Epub 2024 May 20.

Authors

David Petroff¹, Thomas Berg², Johannes Wiegand³

Affiliations

¹ Clinical Trial Centre Leipzig, Leipzig University, Germany.
² Division of Hepatology, Department of Medicine II, Leipzig University Medical Centre, Germany.
³ Division of Hepatology, Department of Medicine II, Leipzig University Medical Centre, Germany. Electronic address: [email protected].

PMID: 38777260
DOI: 10.1016/j.jhep.2024.05.018

No abstract available

Publication types

Letter